These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33578137)

  • 1. Oligomonocytic chronic myelomonocytic leukemia. Thoughts and suggestions.
    Lichtman MA
    Blood Cells Mol Dis; 2021 May; 88():102546. PubMed ID: 33578137
    [No Abstract]   [Full Text] [Related]  

  • 2. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.
    Geyer JT; Tam W; Liu YC; Chen Z; Wang SA; Bueso-Ramos C; Oak J; Arber DA; Hsi E; Rogers HJ; Levinson K; Bagg A; Hassane DC; Hasserjian RP; Orazi A
    Mod Pathol; 2017 Sep; 30(9):1213-1222. PubMed ID: 28548124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemia.
    Murali A; Cross D; Mollee P
    Blood Cancer J; 2021 Jan; 11(1):6. PubMed ID: 33414421
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.
    Selimoglu-Buet D; Badaoui B; Benayoun E; Toma A; Fenaux P; Quesnel B; Etienne G; Braun T; Abermil N; Morabito M; Droin N; Solary E; Wagner-Ballon O;
    Blood; 2017 Aug; 130(6):832-835. PubMed ID: 28611023
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic factors in myelodysplastic and myeloproliferative types of chronic myelomonocytic leukemia: a retrospective analysis of 83 patients from a single institution.
    Breccia M; Latagliata R; Mengarelli A; Biondo F; Mandelli F; Alimena G
    Haematologica; 2004 Jul; 89(7):866-8. PubMed ID: 15257942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
    Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
    Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of acute myeloid leukemia evolving into a chronic myelomonocytic leukemia-like state after induction therapy.
    Iwama A; Miwa A; Suzuki T; Komatsu N; Yoshida M; Suda T; Sakamoto S; Miura Y
    Intern Med; 1992 Feb; 31(2):214-7. PubMed ID: 1600270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
    Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
    Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic myelomonocytic leukemia in adults].
    Baudard M; Delmer A; Zittoun R
    Pathol Biol (Paris); 1997 Sep; 45(7):605-11. PubMed ID: 9404487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte subset distribution in myeloproliferative and myelodysplastic/myeloproliferative neoplasms with monocytosis.
    Sorigue M; Arenillas L; Xicoy B; Andrade-Campos M; Navarro JT; Ferrer A; Zamora L; Calvo X
    Leuk Res; 2022 Jan; 112():106771. PubMed ID: 34902713
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Fraison JB; Grignano E; Braun T; Adès L; Chollet-Martin S; Roland-Nicaise P; Fenaux P; Fain O; Mekinian A
    Leuk Lymphoma; 2019 Oct; 60(10):2594-2596. PubMed ID: 30958078
    [No Abstract]   [Full Text] [Related]  

  • 13. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.
    Miguel A; Orero M; Simon R; Collado R; Perez PL; Pacios A; Iglesias R; Martinez A; Carbonell F
    Lab Hematol; 2007; 13(3):98-102. PubMed ID: 17984041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The division of chronic myelomonocytic leukemia (CMML)-1 into CMML-0 and CMML-1 according to 2016 World Health Organization (WHO) classification has no impact in outcome in a large series of patients from the Spanish group of MDS.
    Xicoy B; Triguero A; Such E; García O; Jiménez MJ; Arnán M; Bernal T; Diaz-Beya M; Valcárcel D; Pedro C; Ramos F; Amigo ML; Collado R; Palomo L; Ardanaz MT; Cedena MT; Grau J; Zamora L; Sanz G
    Leuk Res; 2018 Jul; 70():34-36. PubMed ID: 29775844
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile myelomonocytic leukaemia in a very young child--a case report.
    Awasthi A; Dash S; Marwaha RK
    Indian J Pathol Microbiol; 2003 Oct; 46(4):672-3. PubMed ID: 15025378
    [No Abstract]   [Full Text] [Related]  

  • 16. The myelodysplastic syndromes: diagnostic criteria and laboratory evaluation.
    Ho PJ; Gibson J; Vincent P; Joshua D
    Pathology; 1993 Jul; 25(3):297-304. PubMed ID: 8265251
    [No Abstract]   [Full Text] [Related]  

  • 17. CD33 is frequently expressed in cases of myelodysplastic syndrome and chronic myelomonocytic leukemia with elevated blast count.
    Sanford D; Garcia-Manero G; Jorgensen J; Konoplev S; Pierce S; Cortes J; Kantarjian H; Ravandi F
    Leuk Lymphoma; 2016 Aug; 57(8):1965-8. PubMed ID: 26726757
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML.
    Lacronique-Gazaille C; Chaury MP; Le Guyader A; Faucher JL; Bordessoule D; Feuillard J
    Haematologica; 2007 Jun; 92(6):859-60. PubMed ID: 17550865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review.
    Croitoru DO; Huang RS; McMullen EP; Maazi M; Piguet V
    J Am Acad Dermatol; 2024 Oct; 91(4):712-714. PubMed ID: 38906261
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine.
    Infante MS; Muñoz C; Heras C; Foncillas MA; González I; Lucea I; Echavarria E; Aramendi T; Hernández JA
    Eur J Dermatol; 2015; 25(6):622-3. PubMed ID: 26552844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.